Associate at Nzyme Fund

About Us :

Nzyme Fund is a leading investment firm committed to identifying high-potential opportunities across diverse sectors and markets. We leverage a deep understanding of financial markets, cutting-edge technology, and a robust network to drive superior results for our investors. Join us to be part of an innovative and dynamic team shaping the future of investment management.

Position Overview :

We are seeking a highly motivated and analytical Associate to join our investment team in Madrid. The Associate will play a key role in evaluating new investment opportunities, supporting transaction execution, and contributing to portfolio company value creation. This role is ideal for candidates with a solid foundation in finance and a strong interest in building a long-term career in private equity.

Key Responsibilities :

• Deal Execution : Support all aspects of transaction execution including due diligence, financial modeling, valuation, preparation of investment memos, and coordination with external advisors.
• Market Research : Conduct industry research and competitive analysis to identify attractive investment themes and opportunities.
• Financial Analysis : Build and maintain detailed financial models, perform scenario analysis, and assess the financial and operational performance of target companies.
• Portfolio Monitoring : Assist in monitoring the performance of portfolio companies through regular analysis, KPI tracking, and board materials preparation.
• Sourcing Support : Participate in the screening of new deal flow and help manage the deal pipeline.
• Presentation & Reporting : Prepare internal and external presentations for the investment committee and other stakeholders.
• Team Collaboration : Work closely with Vice Presidents, Directors, and Managing Directors to support day-to-day investment activities and strategic initiatives.

Requirements

Qualifications :

What We Offer :

Interested candidates can express their interest now — the selection process will begin in September .